Investments, Funding & Disinvestment

The strategic collaboration aims to combine robotic technology with specialist surgical expertise to strengthen minimally invasive procedures across urology, gynaecology, and general surgery.

Under the partnership, AstraZeneca and UNICEF will train and support 5,000 young people to take part in NCD prevention activities and youth-led health initiatives.

The Ogun State facility is wholly Nigerian-owned and produces dual active ingredient long-lasting insecticidal nets combining a pyrethroid with chlorfenapyr.

The new agreements build on i3’s market access programme, which has facilitated more than 760 tailored introductions and contributed to 165 partnerships, pilots and memoranda of understanding valued at more than US$19 million.

The Paonta Sahib site covers 14 acres and includes approximately 39,000 square metres of built-up manufacturing space.

TLB 33 is a human immunoglobulin G1 monoclonal antibody designed to bind to and neutralise interleukin 33, an immune signalling protein.

The Danish pharmaceutical company will receive exclusive rights to develop, manufacture and commercialise HRS-1596 outside mainland China, Hong Kong, Macau and Taiwan.

The deal comes as pharmaceutical companies increase investment in therapies that target RAS, a family of proteins involved in regulating cell growth and division.

The companies have also signed a non-binding MoU covering a broader global programme to evaluate ivonescimab in combination with additional AstraZeneca oncology therapies.

The development of Accela and NeoArc involved collaboration with an advisory group comprising several cancer research and treatment institutions.